Paper Details 
Original Abstract of the Article :
Recent reports have shown that acute or chronic treatment with selective serotonin reuptake inhibitor (SSRI) or serotonin-noradrenaline reuptake inhibitor (SNRI) causes unpleasant side effects in patients. In the present study, through the use of electroencephalography (EEG) and electromyography (EM...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/syn.20893

データ提供:米国国立医学図書館(NLM)

Sleep Disturbance: A Potential Side Effect of SSRIs and SNRIs

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are widely used antidepressants but can cause unwanted side effects, including sleep disturbance. This study investigated the potential mechanisms underlying sleep disturbance induced by chronic treatment with paroxetine (SSRI) and milnacipran (SNRI). The researchers examined the effects of these drugs on brain activity and neurotransmitter levels in mice.

SSRIs and SNRIs: Potential Contributors to Sleep Disturbance

The study found that chronic treatment with paroxetine or milnacipran significantly induced sleep disturbance in mice, characterized by increased wakefulness and reduced non-rapid eye movement (NREM) sleep. The researchers also observed increased expression of orexin receptors and histamine receptors in the brain, suggesting that these neurotransmitters may play a role in the sleep disturbance associated with these antidepressants. The study provides evidence for the potential involvement of orexinergic and histaminergic systems in the sleep disturbance caused by SSRIs and SNRIs.

Understanding Sleep Disturbance: A Key to Improved Treatment

This research highlights the potential for SSRIs and SNRIs to contribute to sleep disturbance. The study suggests that altered orexinergic and histaminergic signaling may play a role in these sleep disturbances. This understanding is crucial for improving treatment strategies for individuals experiencing sleep problems while on these antidepressants. The study emphasizes the need for careful monitoring and consideration of potential side effects when prescribing these medications.

Dr. Camel's Conclusion

This study sheds light on the potential mechanisms underlying sleep disturbance induced by chronic treatment with SSRIs and SNRIs. The findings suggest that altered orexinergic and histaminergic signaling may contribute to these sleep problems. This understanding is essential for improving treatment strategies and managing sleep disturbances associated with antidepressant use. Remember, a good night's sleep is crucial for overall well-being, and addressing sleep disturbances is an important aspect of effective mental health treatment.

Date :
  1. Date Completed 2011-08-16
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

21157932

DOI: Digital Object Identifier

10.1002/syn.20893

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.